IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-58669-7.html
   My bibliography  Save this article

A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing

Author

Listed:
  • Jing Hu

    (University of Science and Technology of China)

  • Haoyuan Tan

    (University of Science and Technology of China)

  • Meihua Wang

    (University of Science and Technology of China)

  • Shasha Deng

    (University of Science and Technology of China)

  • Mengyao Liu

    (University of Science and Technology of China)

  • Peiyi Zheng

    (University of Science and Technology of China)

  • Anmin Wang

    (University of Science and Technology of China)

  • Meng Guo

    (University of Science and Technology of China)

  • Jin Wang

    (University of Science and Technology of China)

  • Jiayin Li

    (University of Science and Technology of China)

  • Huanwen Qiu

    (University of Science and Technology of China)

  • Chengbing Yao

    (Anhui Genebiol Biotech. LTD)

  • Zhongliang Zhu

    (University of Science and Technology of China
    Anhui Genebiol Biotech. LTD)

  • Chaolu Hasi

    (Inner Mongolia Xilin Gol League)

  • Dongli Pan

    (Zhejiang University School of Medicine)

  • Hongliang He

    (University of Science and Technology of China)

  • Chenghao Huang

    (Xiamen University)

  • Yuhua Shang

    (Anhui Genebiol Biotech. LTD)

  • Shu Zhu

    (University of Science and Technology of China
    Hefei Comprehensive National Science Center)

  • Tengchuan Jin

    (University of Science and Technology of China
    University of Science and Technology of China
    University of Science and Technology of China
    Anhui Genebiol Biotech. LTD)

Abstract

Herpes simplex virus (HSV) causes significant health burden worldwide. Currently used antiviral drugs are effective but resistance can occur. Here, we report two high-affinity neutralizing nanobodies, namely Nb14 and Nb32, that target non-overlapping epitopes in HSV gD. Nb14 binds a neutralization epitope located in the N-A’ interloop, which prevents the interaction between gD and gH/gL during the second step of conformational changes during membrane fusion after virus attachment. The bispecific nanobody dimer (Nb14-32-Fc) exhibits high potency in vitro and in vivo. Mechanistically, Nb14-32-Fc neutralizes HSVs at both the pre-and post-attachment stages and prevents cell-to-cell spread in vitro. Administration of Nb14-32-Fc at low dosage of 1 mg/kg provides 100% protection in an HSV-1 infection male mouse model and an HSV-2 infection female mouse model. Our results demonstrate that Nb14-32-Fc could serve as a promising drug candidate for treatment of HSV infection, especially in the cases of antiviral drug resistance and severe herpes encephalitis.

Suggested Citation

  • Jing Hu & Haoyuan Tan & Meihua Wang & Shasha Deng & Mengyao Liu & Peiyi Zheng & Anmin Wang & Meng Guo & Jin Wang & Jiayin Li & Huanwen Qiu & Chengbing Yao & Zhongliang Zhu & Chaolu Hasi & Dongli Pan &, 2025. "A potent protective bispecific nanobody targeting Herpes simplex virus gD reveals vulnerable epitope for neutralizing," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58669-7
    DOI: 10.1038/s41467-025-58669-7
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-58669-7
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-58669-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58669-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.